MoneyWorks4Me

Speciality Medicines informs about disclosure

19 May 2026 Evaluate
Speciality Medicines has informed that the exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Niraj Shah.

The above information is a part of company’s filings submitted to BSE.
Peers